跳至主要内容
临床试验/NCT06870110
NCT06870110招募中不适用

Brain Training for Substance Use Disorders

Neurotype Inc.2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年1月17日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
40
试验地点
2
主要终点
Change in ERP-Based Classification of Opioid-Related Attention Bias (Probability Score)

研究概览

简要总结

Participants play games designed to train visual attention towards natural, non-drug-related scenarios. A biofeedback loop between gameplay and an electroencephalogram (EEG) system monitors game performance and guides game difficulty.

详细描述

The main purpose of this project is to gather pilot data on neurofeedback games that use electroencephalogram (EEG)-based Attention Bias Modification (ABM) to reduce cue-induced drug craving processes in individuals with Opioid Use Disorder (OUD). The project will involve the use of three empirically-supported and potentially therapeutic games that include drug- (such as pill bottle and syringe) and non-drug-related stimuli (such as food and smiling faces). An EEG system will be used to monitor brain activity during gameplay.

The neurofeedback loop for attention training will be synchronized to cue presentations using EEGs which monitor visual Event-Related Potentials (ERP) signatures of attention. The degree of difficulty (i.e., cue content) on subsequent trials of the game will be determined based on the level of attention measured in the neurofeedback loop.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • OUD patient participants:
  • Admitted into chemical treatment with opioid use being a reason for treatment;
  • DSM-IV-TR diagnosis of OUD;
  • Ability to provide informed consent;
  • A minimum of a 6th grade reading level; and
  • Able and willing to provide own contact information for follow-up visit(s).
  • Control participants:
  • Age- and gender-matched to an OUD patient participant in the study;
  • Ability to provide informed consent;
  • A minimum of a 6th grade reading level;
  • Able and willing to provide own contact information for follow-up visit(s).

排除标准

  • OUD patient participants:
  • Refusal or inability to consent;
  • Pregnant;
  • History of serious neurological illness (e.g., Chronic seizure disorder, Wernicke-Korsakoff Syndrome, Epilepsy, Any history of seizures not caused by withdrawal from substances, Other [please specify]);
  • Inability to see text and photos clearly on the computer display; and
  • Unwillingness to change hairstyle (e.g., braids, pony tails, dreadlocks) or remove wig to accommodate application of the EEG headset, if necessary.
  • Control participants:
  • Refusal or inability to consent;
  • Pregnant;
  • History of serious neurological illness (e.g., Chronic seizure disorder, Wernicke-Korsakoff Syndrome, Epilepsy, Any history of seizures, Other [please specify]);
  • Inability to see text and photos clearly on the computer display;
  • Current or previous problems using opioids, other prescription (prescribed or not prescribed) or illicit drugs;
  • Regular nicotine user (e.g., cigarette smoker, e-cig user) within the past 12 months; and
  • Unwillingness to change hairstyle (e.g., braids, pony tails, dreadlocks) or remove wig to accommodate application of the EEG headset, if necessary.

结局指标

主要结局

Change in ERP-Based Classification of Opioid-Related Attention Bias (Probability Score)

时间窗: Pre- to post-biofeedback session (same day, approximately 30 minutes)

The primary outcome will be the change in ERP-based classification scores (probability values) reflecting opioid-related attention bias. ERP voltages from all electrodes will be classified with coefficients reflecting increased amplitude in Early Posterior Negativity (150 to 300 ms), P300 complex (250 to 450 ms), and Late Positive Potential (400 to 900 ms) windows. Change in classification score from the last minus first block will be evaluated.

Change in Visual Probe Task Reaction Time (milliseconds) to Drug-Related Stimuli

时间窗: Pre- to post-biofeedback session (same day, approximately 30 minutes)

The primary outcome will be the change in reaction time (milliseconds) on the Visual Probe Task, measuring attention bias toward drug-related versus neutral stimuli. Participants will complete the task before and after the biofeedback session. Attention bias is indicated by differences in reaction time when responding to probes replacing drug-related versus neutral stimuli. Improvement is reflected by reduced bias scores, calculated as the difference between reaction times to drug-related versus neutral probes. Change scores from pre- to post-session will be analyzed.

次要结局

  • Change in Rating of Cue Reactivity (1-5 Likert Scale)(Pre- to post-biofeedback for a given scene (same day, approximately 30 seconds))
  • Change in Visual Analog Scale (VAS) Rating of Instantaneous Opioid Craving (1-100)(Pre- to post-biofeedback session (same day, approximately 30 minutes))

研究者

发起方
Neurotype Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Brain Training for Substance Use Disorders | 临床试验